M J van de Vijver

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

L Duchateau, M. J. van de Vijver, J. Peterse, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.

M. J. van de Vijver, S. Linn, D. Nuyten, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2003, British Journal of Cancer.

Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types

P Lambin, B. Krishnapuram, P. Lambin, 2008, British Journal of Cancer.

Ductal carcinoma in situ: a proposal for a new classification.

M. J. van de Vijver, J. Peterse, M. Vijver, 1994, Seminars in diagnostic pathology.

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

M. J. van de Vijver, M. Rookus, M. van Beurden, 2004, British Journal of Cancer.